Efficacy and Safety of Caspofungin for Invasive Pulmonary Aspergillosis Underlying Chronic Obstructive Pulmonary Disease

This study is currently recruiting participants.

Verified March 2012 by The First Affiliated Hospital of Guangzhou Medical University

Sponsor:

Collaborator:

Merck

Information provided by (Responsible Party):

Feng Ye, The First Affiliated Hospital of Guangzhou Medical University

ClinicalTrials.gov Identifier:

NCT01499433

First received: December 16, 2011

Last updated: March 25, 2012

Last verified: March 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	December 2013
Estimated Primary Completion Date:	November 2013 (Final data collection date for primary outcome measure)